Changes in Expression of Vascular Endothelial Growth Factor and Its Receptors in Neonatal Hypoxia-Induced Pulmonary Hypertension

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Pediatric Research

• Publication date

  2005-08-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1203/01.PDR.0000169969.18669.D2PMID 16006432
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of peroxynitrite on sarcoplasmic reticulum Ca2+ pump in pig coronary artery smooth muscle.

  2003cited by this paper
• Intrauterine hypertension decreases lung VEGF expression and VEGF inhibition causes pulmonary hypertension in the ovine fetus.

  2003cited by this paper
• Expression of VEGF and its receptors Flt-1 and Flk-1/KDR is altered in lambs with increased pulmonary blood flow and pulmonary hypertension.

  2003cited by this paper
• Elevated glucose inhibits VEGF-A–mediated endocardial cushion formation

  2003cited by this paper
• Caveolin-1-deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue.

  2003cited by this paper
• Vascular Endothelial Growth Factor-dependent Down-regulation of Flk-1/KDR Involves Cbl-mediated Ubiquitination

  2003cited by this paper
• Vascular Endothelial Growth Factor Causes Pulmonary Vasodilation through Activation of the Phosphatidylinositol-3-Kinase-Nitric Oxide Pathway in the Late-Gestation Ovine Fetus

  2002cited by this paper
• Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure.

  2002cited by this paper
• TBC3711, an ETA Receptor Antagonist, Reduces Neonatal Hypoxia-Induced Pulmonary Hypertension in Piglets

  2001cited by this paper
• Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family.

  2001cited by this paper
• Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death‐dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension

  2001cited by this paper
• Pulmonary vascular endothelial growth factor and Flt-1 in fetuses, in acute and chronic lung disease, and in persistent pulmonary hypertension of the newborn.

  2001cited by this paper
• Role of vascular endothelial growth factor in regulation of physiological angiogenesis.

  2001cited by this paper
• Protein kinase C-beta and oxygen deprivation. A novel Egr-1-dependent pathway for fibrin deposition in hypoxemic vasculature.

  2000cited by this paper
• Functions of the VEGF/VEGF Receptor System in the Vascular System

  2000influential reference
• Decreased synthesis and vasodilation to nitric oxide in piglets with hypoxia-induced pulmonary hypertension.

  2000cited by this paper
• Adenovirus-mediated lung vascular endothelial growth factor overexpression protects against hypoxic pulmonary hypertension in rats.

  2000cited by this paper
• Release and Complex Formation of Soluble VEGFR-1 from Endothelial Cells and Biological Fluids

  2000cited by this paper
• Enhanced expression of vascular endothelial growth factor in lungs of newborn infants with congenital diaphragmatic hernia and pulmonary hypertension

  1999cited by this paper
• Vascular Endothelial Growth Factor Governs Endothelial Nitric-oxide Synthase Expression via a KDR/Flk-1 Receptor and a Protein Kinase C Signaling Pathway*

  1999cited by this paper
• VEGF IN COMPLEX WITH DOMAIN 2 OF THE FLT-1 RECEPTOR

  1999cited by this paper
• Evidence for the existence of a novel pregnancy-associated soluble variant of the vascular endothelial growth factor receptor, Flt-1.

  1998cited by this paper
• VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR).

  1998cited by this paper
• Homologous Up-regulation of KDR/Flk-1 Receptor Expression by Vascular Endothelial Growth Factor in Vitro *

  1998cited by this paper
• Increased vascular endothelial growth factor production in the lungs of rats with hypoxia-induced pulmonary hypertension.

  1998cited by this paper
• Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor.

  1997cited by this paper
• Endothelin receptor changes in hypoxia-induced pulmonary hypertension in the newborn piglet.

  1997cited by this paper
• The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-γ pathway and partially induces mitotic signals in NIH3T3 fibroblasts

  1997influential reference
• Reduced vasodilator response to ANF in hypoxia-induced pulmonary hypertension in the newborn piglet.

  1997cited by this paper
• Up-regulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system.

  1997cited by this paper
• Sapecin B, a novel fly toxin, blocks macroscopic K+ currents in the GH3 rat pituitary cell line.

  1997cited by this paper
• Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

  1996cited by this paper
• Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR.

  1996cited by this paper
• Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

  1996cited by this paper
• Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide.

  1995cited by this paper
• Persistent pulmonary hypertension of the newborn.

  1995cited by this paper
• Recent developments in the pathophysiology and treatment of persistent pulmonary hypertension of the newborn.

  1995cited by this paper
• Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.

  1993cited by this paper
• The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor.

  1992cited by this paper
• Persistent Pulmonary Hypertension of the Newborn

  1991cited by this paper
• Arterial smooth muscle cells in vivo: relationship between actin isoform expression and mitogenesis and their modulation by heparin

  1988cited by this paper
• Actin-isoform pattern as a marker of normal or pathological smooth-muscle and fibroblastic tissues.

  1987cited by this paper
• Expression of actin mRNAs in rat aortic smooth muscle cells during development, experimental intimal thickening, and culture.

  1986cited by this paper
• Persistent pulmonary hypertension of the newborn infant.

  1976cited by this paper
• Closure of the ductus arteriosus in the newborn infant.

  1963cited by this paper

• Deciphering the Counterintuitive Role of Vascular Endothelial Growth Factor Signaling Pathways in Pulmonary Arterial Hypertension

  2026cites this paper
• LncRNA H19 Promotes Angiogenesis in Mouse Pulmonary Artery Endothelial Cells by Regulating the HIF-1α/VEGF Signaling Pathway

  2024cites this paper
• Targeting VEGF-A/VEGFR2 Y949 Signaling-Mediated Vascular Permeability Alleviates Hypoxic Pulmonary Hypertension

  2022cites this paper
• Autocrine S100B in astrocytes promotes VEGF-dependent inflammation and oxidative stress, and causes impairment of neuroprotection

  2021cites this paper
• Autocrine S100B in astrocytes promotes VEGF-dependent inflammation and oxidative stress and causes impaired neuroprotection

  2021cites this paper
• l‐Citrulline treatment alters the structure of the pulmonary circulation in hypoxic newborn pigs

  2020cites this paper
• Reversal effects of low-dose imatinib compared with sunitinib on monocrotaline-induced pulmonary and right ventricular remodeling in rats.

  2018cites this paper
• Gremlin 1 blocks vascular endothelial growth factor signaling in the pulmonary microvascular endothelium

  2018cites this paper
• Melatonin Decreases Pulmonary Vascular Remodeling and Oxygen Sensitivity in Pulmonary Hypertensive Newborn Lambs

  2018cites this paper
• Ventilation-induced changes correlate to pulmonary vascular response and VEGF, VEGFR-1/2, and eNOS expression in the rat model of postnatal hypoxia

  2018cites this paper
• Effects of FHL1 and P21 on hypoxia-induced pulmonary vascular remodeling in neonatal rats

  2017cites this paper
• Pathophysiology, screening and diagnosis of pulmonary hypertension in infants with bronchopulmonary dysplasia - A review of the literature.

  2017cites this paper
• Expression profile of mitochondrial voltage-dependent anion channel-1 (VDAC1) influenced genes is associated with pulmonary hypertension

  2017cites this paper
• Hypoxia-Induced Molecular and Cellular Changes in the Congenitally Diseased Heart: Mechanisms and Strategies of Intervention

  2017influential citation
• Plasma VEGF levels and their relation to right ventricular function in pulmonary hypertension

  2015cites this paper
• The role of vascular endothelial growth factor in pulmonary arterial hypertension. The angiogenesis paradox.

  2014cites this paper
• Inflammatory responses in hypoxic ischemic encephalopathy

  2013cites this paper
• Hemocoagulase atrox reduces vascular modeling in rabbit carotid artery adventitia.

  2013cites this paper
• The use of sildenafil in the treatment of persistent pulmonary hypertension of the newborn: a review of the literature.

  2012cites this paper
• Circulating Cytokines and Growth Factors in Pediatric Pulmonary Hypertension

  2012cites this paper
• Expression of HIF-1 alpha, VEGF and EPO in peripheral blood from patients with two cardiac abnormalities associated with hypoxia.

  2010cites this paper
• Congenital Diaphragmatic Hernia: A pulmonary vascular point of view

  2010cites this paper
• Management of Pulmonary Arterial Hypertension in the Neonatal Unit

  2010cites this paper
• Current and future therapeutic options for persistent pulmonary hypertension in the newborn

  2010cites this paper
• Vascular endothelial growth factor acts through novel, pregnancy-enhanced receptor signalling pathways to stimulate endothelial nitric oxide synthase activity in uterine artery endothelial cells.

  2009cites this paper
• Therapeutic targets in neonatal pulmonary hypertension: linking pathophysiology to clinical medicine

  2008cites this paper
• Persistent pulmonary hypertension of the newborn: therapeutical approach.

  2008cites this paper
• Therapy of pulmonary hypertension in neonates and infants.

  2007cites this paper
• Hypoxia Inducible Factor

  2007cites this paper
• Persistent pulmonary hypertension of the newborn.

  2006cites this paper
• Hypoxia-induced mitogenic factor has proangiogenic and proinflammatory effects in the lung via VEGF and VEGF receptor-2.

  2006cites this paper